Table 1.
Top 20 significant transcripts upregulated and top 20 down-regulated by narsoplimab in TA-TMA patient plasma-exposed MVEC
| Upregulated | LogFC | F | Downregulated | LogFC | F |
|---|---|---|---|---|---|
| RNU6-678P | 5.12 | 2.74 | SLC14A1 | −2.00 | 0.80 |
| MIR4766 | 4.91 | 3.75 | C2orf66 | −1.26 | 1.08 |
| MIR589 | 4.16 | 5.05 | ZNF521 | −0.42 | 2.51 |
| SNORD101 | 1.99 | 1.15 | WFS1 | −0.35 | 2.01 |
| MIR6813 | 1.98 | 0.68 | SRD5A3-AS1 | −0.33 | 0.14 |
| SERPINB2 | 1.90 | 7.81 | KRT7 | −0.30 | 0.86 |
| MIR4477B | 1.70 | 3.38 | IL1R1 | −0.28 | 1.44 |
| CHAC1 | 1.64 | 9.59 | FBLN5 | −0.27 | 3.73 |
| MT1L | 1.60 | 3.94 | SOX18 | −0.25 | 1.67 |
| TM4SF18 | 1.53 | 34.21 | ACAN | −0.21 | 0.36 |
| ASPM | 1.43 | 22.57 | RAB11FIP1 | −0.21 | 1.21 |
| CA2 | 1.42 | 7.41 | JUP | −0.20 | 2.51 |
| MIR762 | 1.41 | 2.03 | PPP1R10 | −0.20 | 1.15 |
| PSAT1 | 1.35 | 25.88 | ALPK3 | −0.20 | 2.48 |
| SPC25 | 1.33 | 8.45 | HOXD9 | −0.20 | 2.00 |
| SNCB | 1.33 | 11.87 | MIR5587 | −0.20 | 0.04 |
| TNFSF15 | 1.32 | 12.53 | TMEM204 | −0.19 | 1.60 |
| ESM1 | 1.26 | 13.92 | DOCK9 | −0.18 | 1.16 |
| TTK | 1.26 | 8.77 | BICD1 | −0.18 | 1.53 |
| TNFSF18 | 1.23 | 9.34 | LOX | −0.18 | 0.70 |